Department of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
Centre for Cardiovascular Medicine and Device Innovation, William Harvey Research Institute, Queen Mary University London, London, UK.
Catheter Cardiovasc Interv. 2021 Oct;98(4):649-655. doi: 10.1002/ccd.29382. Epub 2020 Nov 25.
We sought to describe the prevalence, management strategies and evaluate the prognosis of patients with iatrogenic catheter-induced ostial coronary artery dissection (ICOCAD).
ICOCAD is a rare but potentially devastating complication of cardiac catheterisation. The clinical manifestations of ICOCAD vary from asymptomatic angiographic findings to abrupt vessel closure leading to myocardial infarction and death.
55,968 patients who underwent coronary angiography over a 10-year period were screened for ICOCAD as defined by the National Heart, Lung, and Blood Institute. The management and all-cause mortality were retrieved from local and national databases.
The overall prevalence of ICOCAD was 0.09% (51/55,968 patients). Guide catheters accounted for 75% (n = 37) of cases. Half of the ICOCAD cases involved the right coronary artery while the remaining were related to left main stem (23/51; 45%) and left internal mammary artery (2/51; 4%). Two-thirds of ICOCAD were high grade (type D, E, and F). The majority of cases were type F dissections (n = 18; 66%), of which two third occurred in females in their 60s. The majority of ICOCAD patients (42/51; 82%) were treated with percutaneous coronary intervention while the remaining underwent coronary artery bypass grafting (3/51; 6%) or managed conservatively (6/51; 12%). Three deaths occurred during the index admission while 48/51 patients (94.1%) were safely discharged without further mortality over a median follow-up of 3.6 years.
ICOCAD is a rare but life-threatening complication of coronary angiography. Timely recognition and prompt bailout PCI is a safe option for majority of patients with good clinical outcomes.
我们旨在描述医源性导管诱导的冠状动脉口部夹层(ICOCAD)的发生率、处理策略,并评估其预后。
ICOCAD 是一种罕见但潜在致命的心脏导管术并发症。ICOCAD 的临床表现从无症状的血管造影表现到血管突然闭塞导致心肌梗死和死亡不等。
对 10 年间行冠状动脉造影的 55968 例患者进行 ICOCAD 筛查,其定义为美国国立心肺血液研究所定义的 ICOCAD。从当地和国家数据库中检索处理方法和全因死亡率。
ICOCAD 的总体发生率为 0.09%(51/55968 例患者)。导引导管占 75%(n=37)。51 例 ICOCAD 中有一半涉及右冠状动脉,其余与左主干(23/51;45%)和左内乳动脉(2/51;4%)有关。三分之二的 ICOCAD 为高级别(D、E 和 F 型)。大多数 ICOCAD 为 F 型夹层(n=18;66%),其中三分之二发生在 60 多岁的女性。大多数 ICOCAD 患者(42/51;82%)接受了经皮冠状动脉介入治疗,其余患者接受了冠状动脉旁路移植术(3/51;6%)或保守治疗(6/51;12%)。3 例患者在指数住院期间死亡,48/51 例(94.1%)患者在中位随访 3.6 年后安全出院,无进一步死亡。
ICOCAD 是冠状动脉造影的一种罕见但危及生命的并发症。及时识别和及时 bailoutPCI 是大多数患者的安全选择,可获得良好的临床结局。